Express News | Ocugen Inc - Dsmb Approves Continuation of Ocu410 Armada Phase 1/2 Study

BreakingsDec 19 19:38

Express News | Ocugen Inc: Ocu410 Has a Very Favorable Safety and Tolerability Profile

BreakingsDec 19 19:38

Express News | Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of Ocu410 Armada Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

BreakingsDec 19 19:38

Data and Safety Monitoring Board Reviews Interim Safety Data of Phase 2 Subjects of OCU410 ArMaDa Clinical Trial for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

OcugenDec 19 13:00

Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit

OcugenDec 11 13:00

The small Kennedy effect: Major exodus of pharmaceutical stocks in the USA

Several weeks have passed since Trump nominated Alex Azar as Secretary of Health and Human Services, yet the trend of investors withdrawing from the medical care sector has not diminished. So far this year, the performance of the Health Care Select Sector SPDR Fund (XLV) in comparison to the S&P 500 index is approaching the lowest level in the past thirty years. Goldman Sachs believes that significant economic events may need to occur + related policies become clearer + corporate profit expectations are raised in order to attract investors back.

wallstreetcnDec 9 11:20